NCT02256774View on ClinicalTrials.gov

Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

May 31, 2005

Conditions
Healthy
Interventions
DRUG

BILR 355 BS

DRUG

Combivir®

DRUG

Ritonavir

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY